The peroxisome proliferator-activated receptor-␥ (PPAR␥) high-affinity ligand, 15-deoxy-⌬-12,14-PGJ 2 (15d-PGJ 2 ), is toxic to malignant cells through cell cycle arrest and apoptosis induction. In this study, we investigated the effects of 15d-PGJ 2 on apoptosis induction and expression of apoptosis-related proteins in hepatocellular carcinoma (HCC) cells. 15d-PGJ 2 induced apoptosis in SK-Hep1 and HepG2 cells at a 50 M concentration. Pretreatment with the pan-caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (2-VAD-fmk), only partially blocked apoptosis induced by 40 M 15d-PGJ 2 . This indicated that 15d-PGJ 2 induction of apoptosis was associated with a caspase-3-independent pathway. 15d-PGJ 2 also induced down-regulation of the X chromosome-linked inhibitor of apoptosis (XIAP), Bclx, and apoptotic protease-activating factor-1 in SK-Hep1 cells but not in HepG2 cells. However, 15d-PGJ 2 sensitized both HCC cell lines to TNF-related apoptosis-induced ligand-induced apoptosis. In SK-Hep1 cells, cell toxicity, nuclear factor-B (NF-B) suppression, and XIAP down-regulation were induced by 15d-PGJ 2 treatment under conditions in which PPAR␥ was down-regulated. These results suggest that the effect of 15d-PGJ 2 was through a PPAR␥-independent mechanism. Although cell toxicity was induced when PPAR␥ was down-regulated in HepG2 cells, NF-B suppression and XIAP down-regulation were not induced. In conclusion, 15d-PGJ 2 induces apoptosis of HCC cell lines via caspase-dependent and -independent pathways. In SK-Hep1 cells,
15-deoxy-⌬-12,14-PGJ 2 (15d-PGJ 2 ) is a prostaglandin J 2 (PGJ 2 ) derivative and is a high-affinity ligand selective for peroxisome proliferator-activated receptor-␥ (PPAR␥) (Forman et al, 1995) . 15d-PGJ 2 activates PPAR␥, which is functionally associated with adipocyte development (Forman et al, 1995) , adipocyte differentiation (Kliewer et al, 1995) , and inhibition of inducible nitric oxide synthesis in macrophages (Ricote et al, 1998) . Through these physiologic actions, 15d-PGJ 2 contributes to the maintenance of tissue homeostasis.
Recently, it was reported that PPAR␥ is expressed in malignant cells and that ligand activation affects malignant cell proliferation and growth (Brockman et al, 1998; Chang and Szabo, 2000; Keelan et al, 1999; Motomura et al, 2000; Okano et al, 2002; Rumi et al, 2001; Sarraf et al, 1998; Tsubouchi et al, 2000) . In malignant cells, activation of PPAR␥ induces cell cycle arrest (Brockman et al, 1998; Clay et al, 2001; Koga et al, 2001; Motomura et al, 2000; Rumi et al, 2001) , cell differentiation (Chang and Szabo, 2000; Sarraf et al, 1998) , or apoptosis (Keelan et al, 1999) . These results imply that the PPAR␥ activation pathway may be a possible intervention mode for treatment of hepatocellular carcinomas (HCCs), which are resistant to current treatments.
PPAR␥ contributes to regulation of gene transcription in cells. In particular, activated PPAR␥ inhibits nuclear factor-B (NF-B) activity (Chinetti et al, 1998; Chung et al, 2000; Ji et al, 2001; Petrova et al, 1999; Ricote et al, 1998) , which is associated with cell survival. In macrophages, PPAR␥ activation induces apoptosis by interfering with the antiapoptotic NF-B signaling pathway (Chinetti et al, 1998; Ricote et al, 1998) . NF-B also regulates apoptosis-related gene expression and induces apoptosis-related protein expression in cells (Bui et al, 2001; Foehr et al, 2000; Kreuz et al, 2001; Micheau et al, 2001; Tamatani et al, 1999; Yabe et al, 2001; Yang et al, 2000) , contributing to oncogenesis and tumor escape from immune surveillance (Dhanalakshmi et al, 2002; Hiscott et al, 2001; Javeland et al, 2002; Tan and Waldmann, 2002) .
The fact that the PPAR␥ ligand is a regulator of NF-B activation implies an important association between cell apoptosis induction and PPAR␥ activation. However, few studies describe a relationship between PPAR␥ activation and apoptotic-related protein expression (Ohta et al, 2001 ), particularly in gastrointestinal malignant tumor cells (Toyoda et al, 2002) .
In this study, we investigated the effect of 15d-PGJ 2 on induction of apoptosis and apoptosis-related proteins in human HCC cells. We examined potential mechanisms by which 15d-PGJ 2 induces apoptosis and increases expression of intracellular apoptosisrelated proteins.
Results

The 15d-PGJ 2 PPAR␥ Ligand Induces HCC Cell Apoptosis
We previously showed that PPAR␥ is prevalent in human HCC cells (Okano et al, 2002 ). In the current study, we investigated the effect of 15d-PGJ 2 on the viability of SK-Hep1 and HepG2 HCC cells (Fig. 1a) . As expected, 10 M 15d-PGJ 2 failed to induce significant cytotoxicity in HCC cells after 24-hour incubation. However, 50 M 15d-PGJ 2 did induce effective cell death in SK-Hep1 cells. HepG2 cell viability also was decreased by 50 M 15d-PGJ 2 , although its cytotoxic effect was less than that in SK-Hep1 cells.
We used 4'6-diamidino-2-phenylindole (DAPI) staining to evaluate whether HCC cells undergo apoptosis when treated with 50 M 15d-PGJ 2 . Untreated control cells did not show any typical apoptotic features (Fig.  1, b and d) . In contrast, HCC cells treated with 50 M 15d-PGJ 2 showed typical apoptotic features (Fig. 1, c and e). To verify cellular apoptosis, we used FITCconjugated anti-annexin V antibody to evaluate the extent of phosphatidylserine translocation to the cell surface, such as would occur during apoptosis (Fig. 1 , f to i). Untreated control cells did not show cell surface staining, whereas cells treated with 50 M 15d-PGJ 2 showed cell surface staining of the anti-annexin V antibody, indicative of surface membrane phosphatidylserine expression.
15d-PGJ 2 Induces Apoptosis Via Caspase-3 and Caspase-3 Independent Pathways PPAR␥ is a nuclear hormone receptor controlling gene transcription and regulating expression of cell cycle proteins in malignant cells through apoptosis induction (Koga et al, 2001; Motomura et al, 2000) . It is reported that PPAR␥ activation can enhance apoptosis induced by TNF family receptor stimulation (Goke et al, 2000; Ji et al, 2001; Okano et al, 2002) . Hence, we speculated that PPAR␥ activation might result in activation of the caspase cascade, and we examined a, Effect of 15-deoxy-⌬-12,14-PGJ 2 (15d-PGJ 2 ) stimulation on human hepatocellular carcinoma (HCC) cells HepG2: open bars) . Cells were incubated with 15d-PGJ 2 for 24 hours at the indicated concentrations. Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Data shown are the mean Ϯ SD of five independent experiments. b to e, 4'6-Diamidino-2-phenylindole (DAPI) staining was used to evaluate apoptosis in control, untreated SK-Hep1 (b) and HepG2 cells (d) as well as after 15d-PGJ 2 treatment (50 M) of SK-Hep1 (c) and HepG2 (e) cells. Incubation of 50 M 15d-PGJ 2 induced typical apoptosis features, including nuclear condensation and nuclear fragmentation. f to i, HCC cells were stained with FITC-conjugated anti-annexin V antibody and propidium iodide after incubation in the absence or presence of 50 M 15d-PGJ 2 for 12 hours. Without 15d-PGJ 2 , both SK-Hep1 (f) and HepG2 cells (h) showed only cell nuclei staining. After incubation with 15d-PGJ 2 , cell surface staining with FITC-conjugated anti-annexin V antibody was observed on both SK-Hep1 (g) and HepG2 (i).
the expression of apoptosis-related proteins after 15d-PGJ 2 treatment. Caspase-3 expression was detected in both SK-Hep1 and HepG2 cells before treatment, and incubation with 50 M 15d-PGJ 2 resulted in reduced caspase-3 protein expression in SK-Hep1 cells (Fig. 2a) . Because the anti-caspase-3 antibody does not recognize cleaved caspase-3, the observed reduction is a result of cleavage and activation of caspase-3 after 15d-PGJ 2 treatment. In contrast, no change in caspase-3 expression was observed in HepG2 cells after 50 M 15d-PGJ 2 treatment.
It was possible that a caspase-independent mechanism contributed to the apoptosis induced by 15d-PGJ 2 in HCC cells because HepG2 cells underwent apoptosis without apparent activation of caspase-3. Therefore, we investigated the effect of pretreatment with the pan-caspase inhibitor, benzyloxycarbonylVal-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD-fmk), on 15d-PGJ 2 -induced apoptosis. We observed that 40 M Z-VAD-fmk partially blocked the ability of 15d-PGJ 2 to induce apoptosis in HCC cells (Fig. 2b ), but this was incomplete and the inhibitor did not completely block the apoptosis.
15d-PGJ 2 Induces Down-Regulation of Other Apoptosis-Related Proteins
The previous data showed that apoptosis induction by 15d-PGJ 2 was partially associated with activation of caspase-3, the terminal enzyme of the caspase cascade, suggesting that PPAR␥ activation might modulate other apoptosis-related proteins. Expression of the X chromosome-linked inhibitor of apoptosis (XIAP), Bclx, apoptotic protease-activating factor-1 (Apaf-1), and FLICE/caspase-8-inhibitory protein (FLIP), were analyzed by Western blotting (Fig. 3) . XIAP protein expression in HCC cells was evaluated because XIAP is a principal inhibitor of active caspase-3 in human HCC . We found that XIAP expression decreased in SK-Hep1 cells after 50 M 15d-PGJ 2 incubation, whereas no change was observed in HepG2 cells (Fig. 3) .
It is also known that XIAP interacts with processed caspase-9 and inhibits apoptosis (Silke et al, 2002) . Caspase-9, which can activate several downstream caspases, including caspase-3, is induced by autoactivation via the Apaf-1/cytochrome c complex. Cytochrome c is released from mitochondria, and Bcl-2 family members, including Bclx, are principal regulators of the mitochondria-initiated caspase activation pathway . Hence, we examined expression of Bclx and Apaf-1 after treatment of HCC cells with15d-PGJ 2 (Fig. 3) . Expression of Bclx was slightly down-regulated by 50 M 15d-PGJ 2 in SKHep1 cells, with no change in expression in HepG2 cells. Apaf-1 also was down-regulated by 50 M 15d-PGJ 2 in SK-Hep1 cells, and a 17-kDa fragment was observed, probably as a result of degradation by caspase-3 (Lauber et al, 2001 ). However, Apaf-1 was not down-regulated in treated HepG2 cells, nor was the 17-kDa fragment observed.
FLIP, which acts near the beginning of the caspase cascade and inhibits formation of the death-inducing signal complex , slightly decreased in SK-Hep1 cells, but increased in HepG2 cells after 15d-PGJ 2 treatment. The expression of PPAR␥ was down-regulated in both HCC cell lines (Fig. 3) .
15d-PGJ 2 Enhances TNF-related apoptosis-induced ligand (TRAIL)-Induced Apoptosis in HCC Cells
As shown above, 15d-PGJ 2 seemed to influence apoptosis-related protein expression in HCC cells. Bclx and Apaf-1 are associated with apoptosis induction via a mitochondrial pathway (Tsujimoto and Shimizu, 2000; Zou et al, 1997) , and a recent study revealed that the mitochondrial pathway is an important determinant for apoptosis of tumor cells by TRAIL (Thomas et al, 2000) . Therefore, we examined the effect of 15d-PGJ 2 on TRAIL-induced apoptosis of HCC cells (Fig. 4 ). TRAIL treatment alone (100 ng/ml) had a minimal effect on SK-Hep1 and HepG2 cells. In contrast, both HCC cell lines were effectively killed with 50 M 15d-PGJ 2 , and the rate of cell death was enhanced by costimulation with TRAIL and 15d-PGJ 2 .
15d-PGJ 2 Suppressed NF-B Activation and Induced Down-Regulation of XIAP Expression in HCC Cells
Because PPAR␥ activation inhibits NF-B activity (Chinetti et al, 1998; Chung et al, 2000; Ji et al, 2001; Petrova et al, 1999; Ricote et al, 1998) , we examined the effect of 15d-PGJ 2 on NF-B activation in HCC cells. In SK-Hep1 and HepG2 cells, treatment with 50 ng/ml TNF-␣ effectively induced NF-B activation after 8-hour incubation and 15d-PGJ 2 treatment attenuated its activation (Fig. 5 ). This suppression of NF-B activation by 15d-PGJ 2 was greater in SKHep1 cells than in HepG2 cells.
Since there was no change in XIAP expression in HepG2 cells (Fig. 3) , it was possible that insufficient inhibition of NF-B activation might be a contributing factor. To further analyze XIAP regulation, we transfected HCC cells with an IB␣ expression vector and the cells were tested for inhibition of NF-B activation (Fig. 5b) . NF-B activation was suppressed in the transfected cells, and there was reduced XIAP expression in both SK-Hep1 cells and HepG2 cells. There was no corresponding change in Bclx or caspase-3 expression, suggesting that inhibition of NF-B activation by overexpressing IB␣ selectively affected XIAP down-regulation in HCC cells.
15d-PGJ 2 Effects on HCC Viability Are Independent of PPAR␥ Pathways
Previously, 15d-PGJ 2 was thought to exert its effects on cells exclusively through PPAR␥; however, recent reports describe PPAR␥-independent mechanisms (Harris et al, 2002; Petrova et al, 1999; Rossi et al, 2000; Thieringer et al, 2000; Vaidya et al, 1999) . It is not known whether PPAR␥-independent signaling pathways exist in gastrointestinal malignant tumor cells. Therefore, we induced down-regulation of PPAR␥ in HCC cells using PPAR␥ antisense oligodeoxynucleotides. HCC cells were incubated with 1 M PPAR␥ antisense or sense oligodeoxynucleotides, and expression of PPAR␥ was analyzed by Western blotting. HCC cells transfected with PPAR␥ antisense oligos showed reduced PPAR␥ expression (Fig. 6a) , compared with cells that received sense oligos. In cells transfected with sense oligos, 15d-PGJ 2 induced cell death (Fig. 6b) . This loss of viability was even greater in HCC cells treated with PPAR␥ antisense oligos for both SK-Hep1 cells and HepG2 cells. Collectively, these results suggested that 15d-PGJ 2 affected PPAR␥-independent pathways that contribute to HCC cell death.
15d-PGJ 2 Regulates NF-B Activation Through PPAR␥-Dependent and -Independent Pathways
To further evaluate the ability of 15d-PGJ 2 to influence PPAR␥-independent pathways, we investigated NF-B activation by 15d-PGJ 2 when PPAR␥ was down-regulated. In SK-Hep1 cells, 15d-PGJ 2 inhibited NF-B activation induced by TNF-␣ when PPAR␥ was normally expressed (open bars) or down-regulated (solid bars). However, in HepG2 cells, down-regulation of PPAR␥ interfered with 15d-PGJ 2 effects such that TNF-␣ induced NF-B activation even in the presence of 15d-PGJ 2 (Fig. 7a) . We evaluated expression of apoptosis-related proteins by 15d-PGJ 2 treatment when PPAR␥ expression was down-regulated (Fig.  7b) . In SK-Hep1 cells, 15d-PGJ 2 reduced XIAP expression regardless of the PPAR␥ expression level. Caspase-3 also was down-regulated, but to a greater extent in cells expressing less PPAR␥. There were no changes in XIAP expression after 15d-PGJ 2 treatment of HepG2 cells (Fig. 7b) . 15d-PGJ 2 treatment induced a slight up-regulation of caspase-3 with PPAR␥ down- regulation, compared with cells with normal expression of PPAR␥. Thus, it seemed that 15d-PGJ 2 suppressed NF-B activation through PPAR␥-dependent and -independent mechanisms and regulated XIAP expression in HCC cells (Fig. 8) .
Discussion
In this study we demonstrated that 15d-PGJ 2 , a natural cyclopentenone prostaglandin and PPAR␥ agonist, induced apoptosis in HCC cells. This occurred with variable caspase-3 activation; pretreatment with Z-VAD-fmk, a pan-caspase inhibitor, only partially interfered with the 15d-PGJ 2 induction of apoptosis in HCC cells. This suggests that 15d-PGJ 2 induces apoptosis using both caspase-dependent and -independent pathways in HCC cells. Some reports demonstrate caspase-3-independent apoptotic pathways, including apoptosis induced by exogenous nitric oxide, transforming growth factor-␤, cellpermeable peptide SN50, arsenic trioxide (As 2 O 3 ), NF-B inhibition, or a low-molecular weight fraction of human seminal plasma (Brown et al, 1999; Kolenko et al, 1999; Mohr et al, 1998; Pagliari et al, 2000; Perfettini et al, 2002; Sternsdorf et al, 1999; Untergasser et al, 2001) . It is also reported that a caspaseindependent mechanism is partly involved in the 15d-PGJ 2 -induced apoptosis of malignant cells (Nishida et al, 2002) , which is consistent with the current findings.
During caspase-3-independent apoptosis, several studies show mitochondrial potential changes and a, Effects of 15d-PGJ 2 on NF-B activation after TNF-␣ treatment of HCC cells. Cells were incubated with 50 ng/ml TNF-␣ alone (open bars) or pretreated for 24 hours with 50 ng/ml TNF-␣ followed by 50 M 15d-PGJ 2 (solid bars). Reporter gene activity was measured 6 hours after treatment. NF-B activation was assessed by a luciferase assay. Data shown are the mean Ϯ SD of three independent experiments. b, Expression of apoptotic-related proteins (XIAP and caspase-3) after transient transfection with IB␣ expression vector or control vector. Protein expression was analyzed by Western blotting. The IB␣ vector transfection induced a decrease in XIAP expression levels but did not affect caspase-3.
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Laboratory Investigation • October 2003 • Volume 83 • Number 10 changes in expression of antiapoptotic proteins (Pagliari et al, 2000; Untergasser et al, 2001 ). Our study also demonstrated down-regulation of XIAP, Bclx, and Apaf-1 by 15d-PGJ 2 in SK-Hep1 cells. In contrast, FLIP was not down-regulated in SK-Hep1 and HepG2 cells, and no changes in apoptosis-related proteins were observed in HepG2 cells. Because degradation of FLIP by PPAR␥ ligand is possible (Kim et al, 2002) , the differences we observe may be characteristic of each HCC cell line. Down-regulation of these antiapoptotic proteins may promote TRAIL-induced apoptosis in HCC cells. Because 15d-PGJ 2 treatment enhanced cell death induced by TRAIL in HepG2 cells, other apoptosis-related proteins may be affected by 15d-PGJ 2 , such as Bcl-2, Bax, inhibitor of apoptosis-1, or inhibitor of apoptosis-2. The functional basis that links expression of these apoptosis-related proteins and 15d-PGJ 2 treatment should be assessed to more fully understand PPAR␥-induced apoptosis of malignant cells.
NF-B activation induces specific gene expression that tightly regulates programmed cell death and inhibition of apoptosis (Barkett and Gilmore, 1999; Beg et al, 1995; Schmid and Adler, 2000) . In agreement with previous reports (Chinetti et al, 1998; Chung et al, 2000; Ji et al, 2001; Petrova et al, 1999; Ricote et al, 1998) , our data demonstrated that 15d-PGJ 2 inhibited NF-B activation, particularly in SK-Hep1 cells. However, inhibition of NF-B activation by 15d-PGJ 2 was weak in HepG2 cells. Because overexpression of IB␣ induced downregulation of XIAP expression in both SK-Hep1 and HepG2 cells, XIAP down-regulation by 15d-PGJ 2 in HCC cells may be regulated through NF-B activation and thus the effect of 15d-PGJ 2 on NF-B activation may be weak. On the other hand, Bclx was not down-regulated by overexpression of IB␣. PPAR␥ activation inhibits NF-B activation, as well as phosphatidylinositol-3-kinase/Akt (Goetze et al, 2002) , activator protein-1, and signal transducers and activators of transcription (Ricote et al, 1998) . Inhibition of these pathways by 15d-PGJ 2 may also affect expression of apoptosis-related proteins in HCC cells.
Although 15d-PGJ 2 is a high-affinity ligand for PPAR␥ and is associated with cell death and gene expression through PPAR␥ activation, 15d-PGJ 2 also has PPAR␥-independent signaling pathways. These independent mechanisms include suppression of inducible nitric oxide synthase activity (Hortelano et al, 2000; Petrova et al, 1999) , modulation of reactive oxygen intermediates production (Vaidya et al, 1999) , induction of IL-8 (Harris et al, 2002) , stimulation of apoptosis of hepatic myofibroblasts (Li et al, 2001) , and inhibition of NF-B and activator protein-1 activation (Boyault et al, 2001) . In this study, we demonstrated that 15d-PGJ 2 was toxic to HCC cells and suppressed NF-B activation through a PPAR␥-independent pathway in SK-Hep1 cells. However, in HepG2 cells, suppression of NF-B activation was not observed in cells with low PPAR␥ expression, although apoptosis was induced. This suggests that apoptosis by 15d-PGJ 2 is induced mainly via a PPAR␥-independent mechanism in HCC cells. The effect of 15d-PGJ 2 on NF-B activation by may be influenced by dual, overlapping pathways that may or may not involve PPAR␥. In SK-Hep1 cells, 15d-PGJ 2 may inhibit NF-B activation via primarily a PPAR␥-independent mechanism, whereas in HepG2 cells, a PPAR␥-dependent mechanism may predominate.
In SK-Hep1 cells, reduced XIAP expression was observed in cells with normal and down-regulated PPAR␥ expression levels after suppression of NF-B by 15d-PGJ 2 . This result supports the notion that 15d-PGJ 2 regulates XIAP expression via a PPAR␥-independent mechanism in SK-Hep1 cells. Because the ability of 15d-PGJ 2 to inhibit NF-B activation was relatively weak in HepG2 cells (Fig. 5a) , XIAP expression may not be regulated by 15d-PGJ 2 , irrespective of PPAR␥ expression in HepG2 cells. XIAP downregulation, which sensitizes tumor cells to TRAILinduced apoptosis, may be an alternative treatment pathway, possible via TNF-␣ or Fas.
In conclusion, 15d-PGJ 2 induces apoptosis in HCC cells and inhibits NF-B activation and XIAP expression via a PPAR␥-independent mechanism. There are malignant cells with minimal or no PPAR␥ expression (Elstner et al, 1998; Ohta et al, 2001 ), suggesting that cell toxicity pathways independent of PPAR␥ should be further investigated for induction of tumor cell apoptosis. Downregulation of apoptosis inhibitory proteins by 15d-PGJ 2 may increase the sensitivity of tumor cells to TRAIL and sensitize them to TNF-family receptor signaling, opening up new opportunities for therapeutic intervention.
Materials and Methods
Cell Lines and Reagents
The HCC cell lines, HepG2 and SK-Hep1 cells, were purchased from the American Type Culture Collection (Rockville, Maryland). HLE (JCRB 0404) was purchased from the Health Science Research Resource Bank (Osaka, Japan). These cell lines were cultured in DMEM (Dainippon Pharmaceutical Company, Ltd., Osaka, Japan) at 37°C. All media were supplemented with 1% penicillin/streptomycin (GIBCO BRL, Grand Island, New York) and 10% heat-inactivated FCS (GIBCO BRL). 15d-PGJ 2 was purchased from Cayman Chemicals (Ann Arbor, Michigan). Anti-Caspase-3, Bclx, and Apaf-1 antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, California). Anti-FLIP antibody was purchased from Millennium Biotechnology (Romona, California). Anti-XIAP antibody was purchased from BD Bioscience (Franklin Lakes, New Jersey). Anti-PPAR␥1,2 polyclonal antibody was purchased from CALBIOCHEM (San Diego, California).
Assessment of HCC Cell Viability
To assess HCC cell viability, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was performed. The HCC cells were plated at a density of 5 ϫ 10 3 cells per well in 96-well microtiter plates (Corning Glass Works, Corning, New York), and each plate was incubated for 24 hours at 37°C in 5% CO 2 . Each reagent was added, and the plate was incubated for 24 hours. The live-cell count was determined using a Cell Titer 96 assay kit (Promega, Madison, Wisconsin) according to the manufacturer's instructions. The absorbance of each well was measured at 570 nm with a microtiter plate reader (Bio-Rad Laboratories, Hercules, California).
Detection of Apoptosis
A total of 2 ϫ 10 4 HCC cells per well was cultured in an 8-well Lab-tek II chamber slide (Nalge Nunc International, Rochester, New York) for 24 hours, followed by addition of 50 M 15d-PGJ 2 (Cayman Chemicals). After incubation for 24 hours, cell nuclei were stained with DAPI (Sigma, St. Louis, Missouri) and observed with a fluorescence microscope (Zeiss, Göttingen, Germany). To detect early apoptotic changes, cells were incubated with 50 M 15d-PGJ 2 for 12 hours, and expression of cell surface phosphatidylserine was determined with an Annexin V-FITC apoptosis detection kit (MBL Company, Ltd., Nagoya, Japan).
Western Blotting Analysis of HCC Cell Extracts After 15d-PGJ 2 Stimulation
HCC cells (4 ϫ 10 5 ; SK-Hep1, HLE, or HepG2) were grown in 60-mm dishes for 24 hours at 37°C in 5% CO 2 the day before reagent addition. HCC cells were incubated with 0, 10, or 50 M 15d-PGJ 2 (Caymen Chemicals) for 24 hours at 37°C in 5% CO 2 . After incubation, HCC cells were harvested and lysed in lysis buffer (50 mmol/L Tris-HCl, pH 8, 150 mmol/L NaCl, 5 mmol/L ethylenediaminetetraacetic acid, 1% NP-40, 1 mmol/L phenylmethylsulfonyl fluoride) on ice. After centrifugation, supernatants were collected and their protein content was measured using a BioRad Protein Assay kit (Bio-Rad Laboratories). Equal amounts of protein from each extract were separated by 14% SDS-PAGE and transferred onto nitrocellulose membranes (Toyo Roshi, Tokyo, Japan) using the Bio-Rad electrotransfer system. Blots were blocked by incubation in 5% nonfat dried milk in Tris-buffered saline overnight at 4°C and probed for 2 hours at room temperature with each antibody. Antibodies were diluted 1:1000 with 0.05% Tween 20 in Trisbuffered saline. The immunoblots were then probed with horseradish peroxidase-conjugated anti-rabbit IgG (Amersham Biosciences Corp., Piscataway, New Jersey), anti-mouse IgG (Santa Cruz Biotechnology), or anti-goat IgG (Zymed Laboratory Inc., South San Francisco, California) at 1:2000 dilutions in 5% nonfat dried milk in Tris-HCl, pH 7.5, and 0.05% Tween 20. After the final washing, signal was detected with an ECL kit (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom).
NF-B Luciferase Reporter Gene Assay
The pNF-B-Luc Vector (Mercury Pathway Profiling System) and pCMV-IB␣ were obtained from Clontech (San Diego, California). Human HCC cells (2 ϫ 10 5 ) were grown in 6-well plates (NUNC Brand Products, Demmark) the day before transfection. Cells were transfected using FuGENE 6 (Boehringer Mannheim, Mannheim, Germany) according to the manufacturer's protocol. HCC cells were pretreated with 50 ng/ml TNF-␣ for 2 hours before treatment with 50 M 15d-PGJ 2 . Reporter gene activity was measured 6 hours after 15d-PGJ 2 treatment.
PPAR␥ Antisense Oligodeoxynucleotide Transfection in HCC Cells
To inhibit PPAR␥ protein expression in HCC cells, phosphorothiorate antisense oligodeoxynucleotides were used to inhibit the FLIP initiation codon. Control cells were transfected with sense oligodeoxynucleoti-
Figure 8.
A schematic outline of the proposed mechanism of 15d-PGJ 2 signaling pathways in SK-Hep1 and HepG2 HCC cell lines. Cell toxicity with 15d-PGJ 2 is exerted through a PPAR␥-independent pathway in both SK-Hep1 and HepG2 cells. Cell toxicity with 15d-PGJ 2 partially accompanies caspase-3 activation in SK-Hep1 cells. In HepG2 cells, 15d-PGJ 2 weakly activates caspase-3. NF-B activation is differentially suppressed in SK-Hep1 and HepG2 cells. In SK-Hep1 cells, 15d-PGJ 2 suppresses NF-B activation through a PPAR␥-independent pathway, whereas in HepG2 cells the signaling pathway of NF-B suppression by 15d-PGJ 2 is via PPAR␥. The suppression of NF-B activation results in XIAP down-regulation in both HCC cell lines.
des. The following sequences were used (Nikitakis et al, 2002) : PPAR␥ antisense, 5'-ctctgtgtcaaccatggtca-3'; PPAR␥ sense, 5'-atgaccatggttgacacaga-3'. A total of 5 ϫ 10 5 HCC cells per well was transfected with 1 M PPAR␥ antisense or sense oligodeoxynucleotides using FuGENE 6 (Boehringer Mannheim) according to the manufacturer's protocol and incubated for 24 hours at 37°C. PPAR␥ expression was analyzed by Western blotting.
